The importance of including the C-terminal domain of PTP1B1-400 to identify potential antidiabetic inhibitors
In the present work, we studied the inhibitory and kinetic implications of classical PTP1B inhibitors (chlorogenic acid, ursolic acid, suramin) using three enzyme constructs (hPTP1B1-285, hPTP1B1-321, and hPTP1B1-400). The results indicate that the unstructured region of PTP1B (300-400 amino acids)...
Main Authors: | Andrea Coronell-Tovar, Francisco Cortés-Benítez, Martin González-Andrade |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2023.2170369 |
Similar Items
-
Dithiocarbamates as potential PTP1B inhibitors for diabetes management
by: Tanvi A. Deshpande, et al.
Published: (2022-01-01) -
PTP1B Inhibitors from the Entomogenous Fungi Isaria fumosorosea
by: Jun Zhang, et al.
Published: (2017-11-01) -
Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling
by: Claudia Penafuerte, et al.
Published: (2017-06-01) -
ETS proto-oncogene 1 modulates PTP1B expression to participate in high glucose-mediated endothelial inflammation
by: Jiang Lili, et al.
Published: (2022-03-01) -
PTP1B triggers integrin-mediated repression of myosin activity and modulates cell contractility
by: Ana E. González Wusener, et al.
Published: (2016-01-01)